Evidence map›Paper›PMID 33614266›Full record

ArticlePeerJ2021

Effects of pharmaceutically active compounds (PhACs) on fish body and scale shape in natural waters.

Adam Staszny, Peter Dobosy, Gabor Maasz, Zoltan Szalai, Gergely Jakab, Zsolt Pirger, Jozsef Szeberenyi, Eva Molnar, Lilianna Olimpia Pap, Vera Juhasz and 4 more

Abstract read
In one paragraph

Article in PeerJ, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Adam StasznyDepartment of Freshwater Fish Ecology, Institute of Aquaculture and Environmental Safety, Hungarian University of Agriculture and Life Sciences, Gödöllő, Hungary.
Peter DobosyDanube Research Institute, MTA-Centre for Ecological Research, Budapest, Hungary.
Gabor MaaszBalaton Limnological Institute, MTA-Centre for Ecological Research, Tihany, Hungary.
Zoltan SzalaiGeographical Institute, Research Centre for Astronomy and Earth Sciences, MTA Centre for Excellence, Budapest, Hungary.ORCID 0000-0001-5267-411X
Gergely JakabGeographical Institute, Research Centre for Astronomy and Earth Sciences, MTA Centre for Excellence, Budapest, Hungary.ORCID 0000-0001-5424-1983
Zsolt PirgerBalaton Limnological Institute, MTA-Centre for Ecological Research, Tihany, Hungary.
Jozsef SzeberenyiGeographical Institute, Research Centre for Astronomy and Earth Sciences, MTA Centre for Excellence, Budapest, Hungary.
Eva MolnarBalaton Limnological Institute, MTA-Centre for Ecological Research, Tihany, Hungary.
Lilianna Olimpia PapDepartment of Freshwater Fish Ecology, Institute of Aquaculture and Environmental Safety, Hungarian University of Agriculture and Life Sciences, Gödöllő, Hungary.
Vera JuhaszDepartment of Freshwater Fish Ecology, Institute of Aquaculture and Environmental Safety, Hungarian University of Agriculture and Life Sciences, Gödöllő, Hungary.
Andras WeiperthDepartment of Freshwater Fish Ecology, Institute of Aquaculture and Environmental Safety, Hungarian University of Agriculture and Life Sciences, Gödöllő, Hungary.
Bela UrbanyiInstitute of Aquaculture and Environmental Safety, Hungarian University of Agriculture and Life Sciences, Gödöllő, Hungary.
Attila Csaba KondorGeographical Institute, Research Centre for Astronomy and Earth Sciences, MTA Centre for Excellence, Budapest, Hungary.
Arpad FerinczDepartment of Freshwater Fish Ecology, Institute of Aquaculture and Environmental Safety, Hungarian University of Agriculture and Life Sciences, Gödöllő, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, there are growing concerns about pharmaceutically active compounds (PhACs) in natural ecosystems. These compounds have been found in natural waters and in fish tissues worldwide. Regarding their growing distribution and abundance, it is becoming clear that traditionally used risk assessment methodologies and ecotoxicological studies have limitations in several respects. In our study a new, combined approach of environmental impact assesment of PhACs has been used.

methodsIn this study, the constant watercourses of the suburban region of the Hungarian capital (Budapest) were sampled, and the body shape and scale shape of three fish species (roach

resultsSignificant connections were found between shape and PhACs concentrations in several cases. Despite the relatively large number of compounds (54) detected, citalopram, propranolol, codeine and trimetazidine significantly affected only fish body and scale shape, based on their concentrations. These four PhACs were shown to be high (citalopram), medium (propranolol and codeine), and low (trimetazidine) risk levels during the environmental risk assessment, which were based on Risk Quotient calculation. Furthermore, seven PhACs (diclofenac, Estrone (E1), tramadol, caffeine 17α-Ethinylestradiol (EE2), 17α-Estradiol (aE2), Estriol (E3)) were also categorized with a high risk level. However, our morphological studies indicated that only citalopram was found to affect fish phenotype amongst the PhACs posing high risk. Therefore, our results revealed that the output of (traditional) environmental/ecological risk assessment based on ecotoxicological data of different aquatic organisms not necessarily show consistency with a "real-life" situation; furthermore, the morphological investigations may also be a good sub-lethal endpoint in ecotoxicological assessments.

Indexed as

ChubGibel carpLandmark-based geometric morphometricsRoachShape analysis

Identifiers

PMID33614266
PMCPMC7882141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.